Nothing Special   »   [go: up one dir, main page]

KR100320772B1 - Process for Preparation of (S)-Benzoxazine Derivatives and Process for Racemization of (R)-Benzoxazine Derivatives - Google Patents

Process for Preparation of (S)-Benzoxazine Derivatives and Process for Racemization of (R)-Benzoxazine Derivatives Download PDF

Info

Publication number
KR100320772B1
KR100320772B1 KR1019990016338A KR19990016338A KR100320772B1 KR 100320772 B1 KR100320772 B1 KR 100320772B1 KR 1019990016338 A KR1019990016338 A KR 1019990016338A KR 19990016338 A KR19990016338 A KR 19990016338A KR 100320772 B1 KR100320772 B1 KR 100320772B1
Authority
KR
South Korea
Prior art keywords
compound
benzoxazine
dihydro
alkyl
dihalogeno
Prior art date
Application number
KR1019990016338A
Other languages
Korean (ko)
Other versions
KR20000047396A (en
Inventor
츄파킨올레그니콜라에비치
크라스노프빅터파블로비치
레비트갈리나르보브나
챠루신발레리니콜라에비치
코롤요바마리나아나토리에브나
쵸이엘리자베타블라디미로브나
이호성
박영준
김민환
김경철
Original Assignee
유현식
삼성종합화학주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유현식, 삼성종합화학주식회사 filed Critical 유현식
Publication of KR20000047396A publication Critical patent/KR20000047396A/en
Application granted granted Critical
Publication of KR100320772B1 publication Critical patent/KR100320772B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

(RS)-3-알킬-7,8-디할로게노-2,3-다히드로-4H[1,4]벤족사진 라세미체 화합물과 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 1 : 0.5∼0.6의 몰비로 유기용매 내에서 혼합하여 반응시키고; 산 수용액을 첨가하여 다량의 (R)-1 화합물이 함유된 미반응물과 N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진이 함유된 유기층 물질을 분리하고; 상기 유기층 물질을 세척, 건조, 활성탄처리, 여과, 및 감압증류한 후 얼음용기하에서 비극성용매를 가하여 여과함으로써 N-[(2S)-2-(6-메톡시나프틸-2-일]-(3S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진Ⅰ 화합물과 Ⅱ 화합물을 분리하고; 상기 벤족사진Ⅰ 화합물에 산을 가하여 가수분해함으로써 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물을 얻는다. 상기 과정에서 분리된 벤족사진Ⅱ 화합물에 산을 가하여 가수분해하고, 여기에 다량의 (R)-1 화합물을 함유한 상기 미반응물을 가하고, 이 혼합용액에 0.1∼1몰비의 산을 가하여 100∼150℃의 온도에서 5∼20시간동안 라세미화 반응시켜 (RS)-1 라세미체 화합물을 제조한다.(RS) -3-alkyl-7,8-dihalogeno-2,3-dahydro-4H [1,4] benzoxazine racemic compound and (S) -2- (6-methoxynaphthyl- 2-yl) propionyl chloride is reacted by mixing in an organic solvent in a molar ratio of 1: 0.5 to 0.6; Aqueous acid solution containing N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S) -3- Separating the organic layer material containing alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine; The organic layer material was washed, dried, treated with activated carbon, filtered, and distilled under reduced pressure, followed by filtration by adding a nonpolar solvent under an ice container to obtain N-[(2S) -2- (6-methoxynaphthyl-2-yl]-( 3S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine I compound and compound II were separated; an acid was added to the benzoxazine I compound to hydrolyze it This gives (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound. An acid was added to the compound to hydrolyze it, and the above unreacted product containing a large amount of (R) -1 compound was added thereto, and 0.1 to 1 molar ratio of acid was added to the mixed solution, and 5 to 20 at a temperature of 100 to 150 ° C. A racemization reaction was performed for a time to prepare a (RS) -1 racemate compound.

Description

(S)-벤족사진 유도체의 제조방법 및 (R)-벤족사진 유도체의 라세미화 방법{Process for Preparation of (S)-Benzoxazine Derivatives and Process for Racemization of (R)-Benzoxazine Derivatives}Process for Preparation of (S) -Benzoxazine Derivatives and Process for Racemization of (R) -Benzoxazine Derivatives}

발명의 분야Field of invention

본 발명은 (S)-벤족사진(benzoxazine) 유도체의 제조방법 및 (R)-벤족사진 유도체의 라세미화(racemization) 방법에 관한 것이다. 보다 구체적으로 본 발명은 강력한 항균작용을 갖는 레보플록사신(levofloxacin) 및 그 유사 화합물의 제조에 유용한 중간체인 (S)-벤족사진 유도체를 라세미체인 벤족사진(RS)-1 화합물과 분할제로서 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 반응시켜 제조하고, 상기 (S)-벤족사진 유도체의 제조과정에서 발생되는 화합물과 미반응된 (R)-벤족사진 화합물을 반응시켜 (R)-벤족사진 화합물을 라세미화하는 방법에 관한 것이다.The present invention relates to a method for preparing a (S) -benzoxazine derivative and a racemization method for a (R) -benzoxazine derivative. More specifically, the present invention provides a (S) -benzoxazine derivative, which is a useful intermediate for the preparation of levofloxacin and similar compounds having a strong antimicrobial activity, as a racemic benzoxazine (RS) -1 compound and a splitting agent (S). )-(6-methoxynaphthyl-2-yl) propionyl chloride, and reacted with the compound generated during the preparation of the (S) -benzoxazine derivative. A method of reacting a compound to racemate a (R) -benzoxazine compound.

발명의 배경 및 종래기술Background of the Invention and Prior Art

(S)-벤족사진 유도체의 하나인 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물을 제조하기 위한 여러 가지 방법들이 알려져 있다. (S)-벤족사진 유도체는 강력한 항균작용을 갖는 레보플록사신 및 그 유사 화합물의 제조에 유용한 중간체이다.Preparation of (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound, which is one of the (S) -benzoxazine derivatives Various methods are known for doing this. (S) -benzoxazine derivatives are useful intermediates for the preparation of levofloxacin and similar compounds having potent antibacterial action.

유럽특허 제206,283호에는 L-프롤린의 P-톨루엔설포닐 유도체를 이용한 라세미체 벤족사진 (RS)-1 화합물을 광학 분할하는 방법이 기술되어 있다. 그러나 이 방법은 원하는 벤족사진 유도체(S)-1 화합물을 고광학순도로 얻기 위하여 칼럼 크로마토그래피를 사용하여야 하는 문제가 있다. 또한 상기 특허에는 지방 단백질 리파제(lipase)를 이용하는 광학 이성질체 분리법이 기술되어 있으나 대량 합성법으로는 적합하지 못하다.EP 206,283 describes a method for optically dividing racemate benzoxazine (RS) -1 compounds using P-toluenesulfonyl derivatives of L-proline. However, this method has a problem of using column chromatography to obtain a desired benzoxazine derivative (S) -1 compound with high optical purity. The patent also describes optical isomer separation using fat protein lipase but is not suitable for mass synthesis.

일본공개특허 제1-175,975호에서 D-프롤린의 P-톨루엔설포닐 유도체를 이용한 라세미체 벤족사진 (RS)-1 화합물의 광학 분할법이 기술되어 있으나, 여기서 사용되는 D-프롤린은 비교적 고가이고 라세미체 벤족사진 (RS)-1 화합물 1몰당 1.2몰 이상의 과량을 사용하여야 하기 때문에 제조원가 측면에서 불리하다.Japanese Patent Laid-Open No. 1-175,975 describes the optical cleavage of racemic benzoxazine (RS) -1 compounds using P-toluenesulfonyl derivatives of D-proline, but the D-proline used here is relatively expensive It is disadvantageous in terms of production cost because an excess of 1.2 moles or more per mole of racemic benzoxazine (RS) -1 compound must be used.

유럽특허 제304,684호에는 (R)-(-)-캠퍼-10-설폰산과 라세미체 벤족사진 (RS)-1 화합물의 염형성법을 이용한 광학 이성질체 분리법이 기재되어 있으나, 이 방법으로는 고광학순도의 (S)-1 화합물을 얻을 수 없다.EP 304,684 discloses optical isomer separation using salt formation of (R)-(-)-camphor-10-sulfonic acid and racemic benzoxazine (RS) -1 compounds, but this method is known as high optical Purity (S) -1 compound could not be obtained.

또한 유럽특허 제273,399호와 제368,410호에는 광학 이성질체 합성법이 기재되어 있으나 단계가 복잡하고 수율이 낮으며 고광학순도의 (S)-1 화합물을 얻을 수없다.In addition, European Patent Nos. 273,399 and 368,410 describe optical isomer synthesis methods, but complicated steps, low yields, and high optical purity (S) -1 compounds cannot be obtained.

상기와 같은 문제점을 해결하기 위하여, 본 발명자들은 고광학순도를 갖고 값싸게 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체(S)-1 화합물을 얻을 수 있는 방법을 개발하기에 이른 것이다.In order to solve the above problems, the present inventors have high optical purity and inexpensively (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine It is early to develop a method for obtaining a derivative (S) -1 compound.

본 발명의 목적은 고광학순도를 갖는 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물을 얻을 수 있는 방법을 제공하기 위한 것이다.An object of the present invention is to obtain (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound having high optical purity It is intended to provide a way to do this.

본 발명의 다른 목적은 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물을 값싸게 제조할 수 있는 방법을 제공하기 위한 것이다.Another object of the present invention is to provide a (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound at low cost. It is to provide a way.

본 발명의 또 다른 목적은 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물의 제조과정에서 발생하는 미반응된 (R)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (R)-1 화합물을 라세미화하는 방법을 제공하기 위한 것이다.Another object of the present invention arises during the preparation of (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound To provide a method of racemizing an unreacted (R) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (R) -1 compound It is for.

본 발명의 상기 및 기타의 목적들은 하기 설명되는 본 발명에 의해 모두 달성될 수 있다.The above and other objects of the present invention can be achieved by the present invention described below.

본 발명에 따른 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체[(S)-1], (R)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체[(R)-1] 및 (RS)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체[(RS)-1]는 하기식으로 표시된다:(S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivatives according to the invention [(S) -1], (R) -3- Alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivatives [(R) -1] and (RS) -3-alkyl-7,8-dihalogeno- The 2,3-dihydro-4H [1,4] benzoxazine derivative [(RS) -1] is represented by the formula:

상기식에서 X1및 X2는 서로 동일하거나 또는 상이한 할로겐원자이며 바람직하게는 불소원자이고, R은 저급 알킬기이며 바람직하게는 메틸기이다.Wherein X 1 and X 2 are the same or different halogen atoms from each other, preferably a fluorine atom, R is a lower alkyl group, preferably a methyl group.

상기 벤족사진 유도체 (S)-1 화합물은 강력한 항균작용을 갖는 레보플록사신 및 이의 유사화합물의 제조에 유용한 중간체이다.The benzoxazine derivatives (S) -1 compounds are useful intermediates for the preparation of levofloxacin and similar compounds having strong antimicrobial activity.

본 발명자들은 상기 벤족사진 유도체 (RS)-1 라세미체 화합물을 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드에 반응시킬 경우 (S)-1 화합물이 (R)-1 화합물보다 상대적으로 반응이 빨리 진행되어 N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-3-알킬-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체Ⅰ 화합물이 N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-3-알킬-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체Ⅱ 화합물보다 빨리 생성됨을 발견하여 이들 Ⅰ 화합물과 Ⅱ 화합물을 반응속도에 따라 분할할 수 있다는 것을 착안하였다.The inventors have found that when the benzoxazine derivative (RS) -1 racemate compound is reacted with (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride, the (S) -1 compound is ( The reaction proceeds faster than the R) -1 compound, whereby N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S) -3-alkyl-dihalogeno- 2,3-Dihydro-4H [1,4] benzoxazine Derivative I Compound is N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S) -3- It was found to be produced faster than alkyl-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative II compounds and it was conceived that these compounds I and II could be partitioned according to the reaction rate.

상기식에서 X1및 X2는 서로 동일하거나 또는 상이한 할로겐원자이며 바람직하게는 불소원자이고, R은 저급 알킬기이며 바람직하게는 메틸기이다.Wherein X 1 and X 2 are the same or different halogen atoms from each other, preferably a fluorine atom, R is a lower alkyl group, preferably a methyl group.

본 발명에서는 (RS)-1 화합물에 대하여 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 0.5∼0.6몰비로 반응시킴으로써 Ⅰ 화합물을 Ⅱ 화합물에 비하여 다량 생성하고, 원하는 Ⅰ 화합물을 고체상태로 분리하고, 산을 이용하여 가수분해하여 원하는 (S)-1 화합물을 얻을 수 있다. 본 발명에서는 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 분할제로 사용하며, 그 사용량은 종래의 방법에서 사용된 분할제의 양보다 거의 절반 이하이다. 따라서 제조원가를 절감할 수 있다. 예를 들어, 일본공개특허 제1-175,975호에서 분할제로 사용된 D-프롤린은 비교적 고가이고 (RS)-1 화합물 1몰당 1.2몰 이상의 과량을 사용하여야 한다.In the present invention, by reacting (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride with (RS) -1 compound at 0.5 to 0.6 molar ratio, a large amount of compound I is produced compared to compound II. The desired compound I can be separated in the solid state and hydrolyzed with an acid to obtain the desired compound (S) -1. In the present invention, (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride is used as the dividing agent, and its amount used is almost half or less than the amount of the dividing agent used in the conventional method. Therefore, manufacturing cost can be reduced. For example, D-proline used as a dividing agent in Japanese Patent Laid-Open No. 1-175,975 is relatively expensive and an excess of 1.2 moles or more per mole of (RS) -1 compound should be used.

또한 본 발명에서는 고광학순도를 갖는 (S)-1 화합물을 얻을 수 있다. 종래에는 폐기되던 (R)-1 화합물을 라세미화시켜 재사용 함으로써 수율 및 제조원가 측면에서 본 발명은 장점을 갖는다.In the present invention, the compound (S) -1 having high optical purity can be obtained. The present invention has advantages in terms of yield and production cost by racemizing and reusing the previously discarded (R) -1 compound.

상기 (RS)-1 라세미체 화합물에서 X1과 X2가 불소원자이고, R이 메틸기인 경우에 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 반응시켜 본 발명에 따른 (S)-1 화합물을 얻고 미반응된 (R)-1 화합물을 라세미화 반응시키는 반응구조는하기식으로 표시된다:(S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride is reacted when X1 and X2 are fluorine atoms and R is a methyl group in the (RS) -1 racemate compound. The reaction structure for obtaining the (S) -1 compound according to the invention and racemizing the unreacted (R) -1 compound is represented by the following formula:

(RS)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 라세미체 화합물과 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 1 : 0.5∼0.6몰의 비로 유기용매 내에서 혼합하여 반응시킨다. 유기용매로는 디클로로메탄, 1,2-디클로로에탄, 또는 클로로포름이 이용가능하고, 반응온도는 -10∼40℃의 범위가 바람직하다. 유기용매 내에는 트리알킬아민류 또는 피리딘이 존재할 수도 있다.(RS) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine racemic compound and (S) -2- (6-methoxynaphthyl- 2-yl) propionyl chloride is mixed and reacted in an organic solvent in a ratio of 1: 0.5 to 0.6 mol. Dichloromethane, 1,2-dichloroethane, or chloroform can be used as the organic solvent, and the reaction temperature is preferably in the range of -10 to 40 ° C. Trialkylamines or pyridine may be present in the organic solvent.

상기 반응용액에 산 수용액을 첨가하여 다량의 (R)-1 화합물이 함유된 미반응물과 N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진이 함유된 유기층 물질을 분리한다. 상기 (R)-1 화합물이 함유된 미반응물은 물층을 형성하는데, 이를 회수하여 라세미화 반응에 재사용한다.An acid solution was added to the reaction solution, and an unreacted substance containing a large amount of (R) -1 compound and N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S The organic layer material containing) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine is separated. The unreacted material containing the (R) -1 compound forms a water layer, which is recovered and reused in the racemization reaction.

상기 유기층 물질을 세척, 건조, 활성탄처리, 여과 및 감압증류한 후, 얼음용기 하에서 비극성 용매를 가하여 여과함으로써 N-[(2S)-2-(6-메톡시나프틸-2-일)-(3S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진Ⅰ 화합물과 Ⅱ 화합물을 분리한다. 상기 유기층 물질은 물로써 세척하고, 건조제로써 건조시키고, 활성탄으로 처리한 후 여과하고, 용매는 감압 증류하여 제거한다. 그 다음 얼음용기 하에서 비극성 용매를 가하여 생성된 고체를 여과하면 상기 벤족사진Ⅰ 화합물이 분리된다. 비극성 용매에 함유된 Ⅱ 화합물은 회수하여 라세미화 반응에 재사용한다. 여기서 사용된 비극성 용매로는 헥산이 바람직하다.The organic layer material was washed, dried, treated with activated carbon, filtered, and distilled under reduced pressure, and then filtered by adding a nonpolar solvent under an ice container to obtain N-[(2S) -2- (6-methoxynaphthyl-2-yl)-( 3S) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine I and II compounds are separated. The organic layer material is washed with water, dried with a desiccant, treated with activated charcoal and filtered, and the solvent is removed by distillation under reduced pressure. The solid produced by adding a non-polar solvent under an ice container is then filtered to separate the benzoxazine I compound. Compound II contained in the nonpolar solvent is recovered and reused in the racemization reaction. As the nonpolar solvent used here, hexane is preferable.

상기에서 얻어진 벤족사진Ⅰ 화합물에 산을 가하여 가수분해함으로써 (S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진 유도체 (S)-1 화합물을 얻는다. 여기서 사용되는 산은 염산, 황산, 초산, 또는 이들의 혼합산이 있다. 상기 벤족사진Ⅰ 화합물에 산을 가하고 가열하면서 환류시킨다. 초산을 사용한 경우에는, 감압증류하여 초산을 제거하고 얼음용기 하에서 물을 첨가한다. 생성되는 고체를 여과하고 물로 세척한다. 여과액은 수산화나트륨 수용액으로 pH를 조절한다. 디클로로메탄으로 상기 용액을 추출하고 소금물로 세척하고 유기층 물질을 건조제로써 건조시키고 여과한다. 용매를 감압증류로 제거하여 노란색의 오일상 (S)-1 화합물을 얻는다.(S) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine derivative (S)-by hydrolysis by addition of an acid to the benzoxazine I compound obtained above 1 compound is obtained. Acids used herein are hydrochloric acid, sulfuric acid, acetic acid, or mixed acids thereof. An acid is added to the benzoxazine I compound and refluxed while heating. If acetic acid is used, distilled under reduced pressure to remove acetic acid and add water under an ice container. The resulting solid is filtered off and washed with water. The filtrate is adjusted to pH with aqueous sodium hydroxide solution. The solution is extracted with dichloromethane and washed with brine and the organic layer material is dried with a desiccant and filtered. The solvent is removed by distillation under reduced pressure to give a yellow oily (S) -1 compound.

상기 과정에서 분리된 벤족사진Ⅱ 화합물에 산을 가하여 가수분해하고, 여기에 다량의 (R)-1 화합물을 함유한 상기 미반응물을 가한다. 이 경우에도 염산, 황산, 초산 또는 이들의 혼합산이 사용될 수 있다. 상기 혼합용액에 0.1∼1몰비의 산을 가하여 100∼150℃의 온도에서 5∼20시간동안 라세미화 반응시켜 (RS)-1 라세미체 화합물을 제조한다. 여기서 사용되는 산으로는 메틸설폰산, 황산 또는 이들의 혼합산이 있으며, 바람직하기로는 120±10℃의 온도에서 8∼14시간동안 라세미화 반응시킨다.An acid is added to the benzoxazine II compound separated in the above step to hydrolyze, and the unreacted substance containing a large amount of (R) -1 compound is added thereto. In this case too, hydrochloric acid, sulfuric acid, acetic acid or mixed acids thereof may be used. To the mixed solution was added 0.1-1 molar ratio of acid, followed by racemization at a temperature of 100-150 ° C. for 5-20 hours to prepare a (RS) -1 racemic compound. The acid used herein is methylsulfonic acid, sulfuric acid or a mixed acid thereof, preferably racemized for 8 to 14 hours at a temperature of 120 ± 10 ℃.

본 발명은 하기의 실시예에 의하여 보다 구체화될 것이며, 하기의 실시예는 본 발명을 예시하기 위한 것으로 본 발명의 보호 범위를 제한하고자 하는 것은 아니다.The invention will be further illustrated by the following examples, which are intended to illustrate the invention and are not intended to limit the protection scope of the invention.

실시예Example

실시예 1a: (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드의 제조Example 1a: Preparation of (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride

(S)-2-(6-메톡시나프틸-2-일)프로피온산 19.0g을 250ml의 1,2-디클로로에탄에 녹이고 0.1ml의 디메틸포름아미드와 7.8ml의 티오닐클로라이드를 가하였다. 40℃에서 2.5시간동안 교반한 후 용매와 과량의 티오닐클로라이드를 감압증류 제거하여 20.5g의 목적 생성물을 고체상으로 수득하였다.19.0 g of (S) -2- (6-methoxynaphthyl-2-yl) propionic acid was dissolved in 250 ml of 1,2-dichloroethane and 0.1 ml of dimethylformamide and 7.8 ml of thionyl chloride were added. After stirring at 40 ° C. for 2.5 hours, the solvent and excess thionyl chloride were distilled off under reduced pressure to obtain 20.5 g of the desired product as a solid.

1H-NMR(CDCl3) δ(ppm): 1.66(3H, d), 3.71(3H, s), 4.24(1H, q),7.12∼7.76(6H, m)1 H-NMR (CDCl 3) δ (ppm): 1.66 (3H, d), 3.71 (3H, s), 4.24 (1H, q), 7.12 to 7.76 (6H, m)

실시예 1b: N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진의 제조Example 1b N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S) -7,8-difluoro-2,3-dihydro-3- Preparation of Methyl-4H [1,4] benzoxazine

30ml의 디클로로메탄에 3.95g의 (RS)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진을 녹였다. 여기에 30ml의 디클로로메탄에 녹인 2.91g의 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 실온에서 적가하였다. 8시간동안 교반한 후 30ml의 12% 염산용액을 가하였다. 물층은 회수하여 라세미화에 사용한다. 그리고 유기층은 물로 세척 후 MgSO4로 건조시키고 활성탄을 처리 후 여과하였다. 용매를 감압증류 제거하고 얼음용기 하에서 50ml의 헥산을 가하여 생성된 고체를 여과하여 2.55g의 목적 생성물을 수득하였다. 그리고 헥산 여과액은 회수하여 라세미화에 사용한다.3.95 g of (RS) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine was dissolved in 30 ml of dichloromethane. To this was added 2.91 g of (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride dissolved in 30 ml of dichloromethane dropwise at room temperature. After stirring for 8 hours, 30 ml of 12% hydrochloric acid solution was added. The water layer is recovered and used for racemization. The organic layer was washed with water, dried over MgSO 4, and treated with activated carbon and filtered. The solvent was distilled off under reduced pressure, and 50 ml of hexane was added under an ice container, and the resulting solid was filtered to obtain 2.55 g of the desired product. The hexane filtrate is recovered and used for racemization.

m.p. 113∼114℃m.p. 113 ~ 114 ℃

[α]D20+66.5(c=1.4, CHCl3)[α] D 20 +66.5 (c = 1.4, CHCl 3)

UV, λ(nm): 232UV, λ (nm): 232

1H-NMR(DMSO-d6) δ(ppm): 0.49(3H, d), 1.42(3H, d), 3.83(3H, s),1 H-NMR (DMSO-d 6) δ (ppm): 0.49 (3H, d), 1.42 (3H, d), 3.83 (3H, s),

4.1∼4.3(2H, m), 4.54(1H, q), 4.8(1H, m),4.1 to 4.3 (2H, m), 4.54 (1H, q), 4.8 (1H, m),

6.80∼7.81(8H, m)6.80-7.81 (8H, m)

19F-NMR(DMSO-d6) δ(ppm, C6F6): 20.3(1F), 1.57(1F)19F-NMR (DMSO-d6) δ (ppm, C6F6): 20.3 (1F), 1.57 (1F)

원소분석치 C23H21F2NO3Elemental Analysis C23H21F2NO3

실측치 % C 69.70 H 5.33 N 3.53 F 9.54Found% C 69.70 H 5.33 N 3.53 F 9.54

계산치 % C 69.54 H 5.33 N 3.52 F 9.56Calculated% C 69.54 H 5.33 N 3.52 F 9.56

실시예 1c: (S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진의 제조Example 1c: Preparation of (S) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine

20ml의 초산에 20ml의 염산과 1.3g의 N-[(2S)-2-(6-메톡시나프틸-2-일)프로피오닐]-(3S)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진을 가하고 9시간동안 가열 환류하였다. 초산을 감압증류 제거한 후 얼음용기 하에서 물을 첨가하였다. 이 때 생성되는 고체를 여과하고 물로 세척하였다. 여과액을 10N 수산화나트륨 수용액으로 pH 9로 맞추었다. 디클로로메탄으로 추출한 후 소금물로 세척하고 유기층을 MgSO4로 건조시키고 여과하였다. 용매를 감압증류 제거하여 0.61g의 목적물을 노란 오일상으로 수득하였다.In 20 ml of acetic acid, 20 ml of hydrochloric acid and 1.3 g of N-[(2S) -2- (6-methoxynaphthyl-2-yl) propionyl]-(3S) -7,8-difluoro-2, 3-dihydro-3-methyl-4H [1,4] benzoxazine was added and heated to reflux for 9 hours. Acetic acid was distilled off under reduced pressure and water was added under an ice container. The resulting solid was filtered off and washed with water. The filtrate was adjusted to pH 9 with 10N aqueous sodium hydroxide solution. Extracted with dichloromethane and washed with brine, the organic layer was dried over MgSO 4 and filtered. The solvent was distilled off under reduced pressure to yield 0.61 g of the desired product as a yellow oil.

[α]D20-8.9(c=3.5, CHCl3)[α] D 20 -8.9 (c = 3.5, CHCl 3)

UV, λ(nm): 244, 297UV, λ (nm): 244, 297

1H-NMR(DMSO-d6) δ(ppm): 1.09(3H, d), 3.42(1H, m), 3.67(1H, dd),1 H-NMR (DMSO-d 6) δ (ppm): 1.09 (3H, d), 3.42 (1H, m), 3.67 (1H, dd),

4.24(1H, dd), 5.9(1H, s), 6.31(1H, ddd),4.24 (1H, dd), 5.9 (1H, s), 6.31 (1H, ddd),

6.66(1H, ddd)6.66 (1 H, ddd)

19F-NMR(DMSO-d6) δ(ppm, C6F6): 9.36(1F), 0.37(1F)19F-NMR (DMSO-d6) δ (ppm, C6F6): 9.36 (1F), 0.37 (1F)

원소분석치 C9H9F2NOElemental Analysis C9H9F2NO

실측치 % C 58.45 H 4.78 N 7.72 F 20.30Found% C 58.45 H 4.78 N 7.72 F 20.30

계산치 % C 58.38 H 4.90 N 7.57 F 20.52Calculated% C 58.38 H 4.90 N 7.57 F 20.52

실시예 2: (RS)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진의 제조Example 2: Preparation of (RS) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine

실시예 1b에서 회수한 헥산 여과액을 농축하여 실시예 1c와 같은 방법으로 반응시키고 여과하여 얻은 물층을 실시예 1b에서 회수한 물층과 혼합하였다. 수용액을 10N 수산화나트륨 수용액으로 pH 9로 맞추었다. 디클로로메탄으로 추출한 후 소금물로 세척하고 유기층을 MgSO4로 건조시키고 여과하였다. 용매를 감압증류 제거하여 2.37g의 (R)-7,8-디플루오로-2,3-디히드로-3-메틸-4H[1,4]벤족사진((S)-나프록센) 유도체로 전환 후 (RS)-1 화합물(HPLC분석 R : S = 86 : 14)을 회수하였다. 여기에 0.81ml의 메탄설폰산을 가하고 110℃에서 13시간동안 교반하였다. 반응물에 에틸아세테이트를 가하고 탄산수소나트륨 수용액과 소금물로 세척하였다. 유기층을 MgSO4로 건조시키고 실리카겔을 깔고 여과한 후 용매를 감압증류 제거하여 2.13g의 목적물을 노란 오일상으로 수득하였다.The hexane filtrate recovered in Example 1b was concentrated, reacted in the same manner as in Example 1c, and the water layer obtained by filtration was mixed with the water layer recovered in Example 1b. The aqueous solution was adjusted to pH 9 with 10N aqueous sodium hydroxide solution. Extracted with dichloromethane and washed with brine, the organic layer was dried over MgSO 4 and filtered. The solvent was distilled off under reduced pressure to convert 2.37 g of (R) -7,8-difluoro-2,3-dihydro-3-methyl-4H [1,4] benzoxazine ((S) -naproxen) derivative. After (RS) -1 compound (HPLC analysis R: S = 86: 14) was recovered. 0.81 ml of methanesulfonic acid was added thereto and stirred at 110 ° C. for 13 hours. Ethyl acetate was added to the reaction mixture, and the mixture was washed with an aqueous sodium bicarbonate solution and brine. The organic layer was dried over MgSO 4, filtered over silica gel, and the solvent was evaporated under reduced pressure to yield 2.13 g of the desired substance as a yellow oil.

[α]D20 0(c=3.5, CHCl3)[α] D 2 0 0 (c = 3.5, CHCl 3)

본 발명은 고광학순도를 갖는 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (S)-1 화합물을 저렴하게 제조할 수 있는 방법을 제공하며, 또한 상기 화합물의 제조과정에서 발생하는 미반응된 (R)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체 (R)-1 화합물을 라세미화하는 방법을 제공하는 효과를 갖는다The present invention provides a low-cost (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative (S) -1 compound with high optical purity. And an unreacted (R) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzone that occurs during the preparation of the compound. Has the effect of providing a method of racemizing a photographic derivative (R) -1 compound

본 발명의 단순한 변형 내지 변경은 이 분야의 통상의 지식을 가진 자에 의하여 용이하게 이용될 수 있으며, 이러한 변형이나 변경은 모두 본 발명의 영역에 포함되는 것으로 볼 수 있다.Simple modifications and variations of the present invention can be readily used by those skilled in the art, and all such variations or modifications can be considered to be included within the scope of the present invention.

Claims (9)

하기 구조식 Ⅰ으로 표시되는 화합물:Compound represented by the following structural formula (I): 상기식에서 X1및 X2는 서로 동일하거나 또는 상이한 할로겐 원자이고, R은 저급 알킬기임.Wherein X 1 and X 2 are the same or different halogen atoms from each other, and R is a lower alkyl group. 제1항에 있어서, X1과 X2는 불소원자이고, R은 메틸기인 것을 특징으로 하는 화합물.A compound according to claim 1, wherein X 1 and X 2 are fluorine atoms and R is a methyl group. 하기식 (RS)-1으로 표시되는 (RS)-3-알킬-7,8-디할로게노-2,3-디히드로-4H [1,4]벤족사진 라세미체 화합물에 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 유기용매 내에서 반응시키고;(S)-to (RS) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine racemate compound represented by the following formula (RS) -1: 2- (6-methoxynaphthyl-2-yl) propionyl chloride is reacted in an organic solvent; 하기식 Ⅰ으로 표시되는 N-[(2S)-2-(6-메톡시나프틸-2-일)-(3S)-3-알킬-7,8 -디할로게노-2,3-디히드로-4H[1,4]벤족사진 화합물을 분리하고; 그리고N-[(2S) -2- (6-methoxynaphthyl-2-yl)-(3S) -3-alkyl-7,8-dihalogeno-2,3-dihydro represented by the following formula (I): -4H [1,4] benzoxazine compound is isolated; And 상기 분리된 화합물을 가수분해시키는;Hydrolyzing the separated compound; 단계로 이루어지는 것을 특징으로 하는 하기식 (S)-1으로 표시되는 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체의 제조방법:Of (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative represented by the following formula (S) -1, comprising the steps Manufacturing Method: 상기식에서 X1및 X2는 서로 동일하거나 또는 상이한 할로겐 원자이고, R은 저급 알킬기임.Wherein X 1 and X 2 are the same or different halogen atoms from each other, and R is a lower alkyl group. 제3항에 있어서, X1및 X2는 불소원자이고, R은 메틸기인 것을 특징으로 하는 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체의 제조방법.4. (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1] according to claim 3, wherein X 1 and X 2 are fluorine atoms and R is a methyl group. , 4] method of preparing benzoxazine derivatives. 제3항에 있어서, 상기 (RS)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 라세미체 화합물과 상기 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 1 : 0.5∼0.6의 몰비로 혼합하는 것을 특징으로 하는 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체의 제조방법.4. The (S) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine racemic compound according to claim 3, wherein the (S) -2- (S) -3-alkyl-7,8-dihalogeno-2,3- characterized by mixing (6-methoxynaphthyl-2-yl) propionyl chloride in a molar ratio of 1: 0.5 to 0.6. Method for preparing a dihydro-4H [1,4] benzoxazine derivative. 제3항에 있어서, 상기 (RS)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 라세미체 화합물은 상기 라세미체 화합물과 상기 (S)-2-(6-메톡시나프틸-2-일)프로피오닐 클로라이드를 유기용매에서 반응시킨 용액에 산을 처리한 다음, 하기식 (R)-1으로 표시되는 미반응 화합물인 (R)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체를 회수하여 라세미화시켜 제조되는 것을 특징으로 하는 (S)-3-알킬-7,8-디할로게노-2,3-디히드로-4H[1,4]벤족사진 유도체의 제조방법.4. The compound according to claim 3, wherein the (RS) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine racemate compound is selected from the racemate compound and An acid was treated in a solution of (S) -2- (6-methoxynaphthyl-2-yl) propionyl chloride in an organic solvent and then an unreacted compound represented by the following formula (R) -1: R) -3-alkyl-7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivatives obtained by recovery and racemization (S) -3-alkyl Method for preparing a -7,8-dihalogeno-2,3-dihydro-4H [1,4] benzoxazine derivative. 제6항에 있어서, X1과 X2는 불소원자이고, R은 메틸기인 것을 특징으로 하는 라세미화 방법.7. The racemization method according to claim 6, wherein X 1 and X 2 are fluorine atoms, and R is a methyl group. 제6항에 있어서, 상기 산처리는 메틸설폰산, 황산 또는 이들의 혼합산으로 행해지는 것을 특징으로 하는 라세미화 방법.7. The racemization method according to claim 6, wherein the acid treatment is performed with methylsulfonic acid, sulfuric acid or a mixed acid thereof. 제6항에 있어서, 상기 산처리는 100∼150℃의 온도범위에서 5∼20시간 동안 행해지는 것을 특징으로 하는 라세미화 방법.The racemization method according to claim 6, wherein the acid treatment is performed for 5 to 20 hours in a temperature range of 100 to 150 캜.
KR1019990016338A 1998-12-16 1999-05-07 Process for Preparation of (S)-Benzoxazine Derivatives and Process for Racemization of (R)-Benzoxazine Derivatives KR100320772B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35791098A JP3201998B2 (en) 1998-12-16 1998-12-16 Method for producing (S) -benzoxazine derivative and method for racemizing (R) -benzoxazine derivative
JP10-357910 1998-12-16

Publications (2)

Publication Number Publication Date
KR20000047396A KR20000047396A (en) 2000-07-25
KR100320772B1 true KR100320772B1 (en) 2002-01-17

Family

ID=18456573

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990016338A KR100320772B1 (en) 1998-12-16 1999-05-07 Process for Preparation of (S)-Benzoxazine Derivatives and Process for Racemization of (R)-Benzoxazine Derivatives

Country Status (2)

Country Link
JP (1) JP3201998B2 (en)
KR (1) KR100320772B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100397491B1 (en) * 2000-12-05 2003-09-13 이수화학 주식회사 Optically active (S)-benzoxazine derivatives and preparing method of the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01175975A (en) * 1987-12-29 1989-07-12 Dai Ichi Seiyaku Co Ltd Production of (s)-benzoxazine derivative
WO1989007596A1 (en) * 1988-02-15 1989-08-24 Farmitalia Carlo Erba S.R.L. New 1,4-benzoxazine and 1,4-benzothiazine derivatives and process for their preparation
EP0619311A1 (en) * 1992-10-07 1994-10-12 Derivados Del Etilo, S.A. Process for obtaining benzoxazines useful for the synthesis of ofloxacin, levofloxacin and derivatives thereof
US5550125A (en) * 1994-02-03 1996-08-27 Synthelabo 3-(2-aminomethyl)-4-[3-trifluoromethyl)benzoyl]-3-4 dihydro-2h-1,4-benzoxazine derivatives and their therapeutic application

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01175975A (en) * 1987-12-29 1989-07-12 Dai Ichi Seiyaku Co Ltd Production of (s)-benzoxazine derivative
WO1989007596A1 (en) * 1988-02-15 1989-08-24 Farmitalia Carlo Erba S.R.L. New 1,4-benzoxazine and 1,4-benzothiazine derivatives and process for their preparation
EP0619311A1 (en) * 1992-10-07 1994-10-12 Derivados Del Etilo, S.A. Process for obtaining benzoxazines useful for the synthesis of ofloxacin, levofloxacin and derivatives thereof
US5550125A (en) * 1994-02-03 1996-08-27 Synthelabo 3-(2-aminomethyl)-4-[3-trifluoromethyl)benzoyl]-3-4 dihydro-2h-1,4-benzoxazine derivatives and their therapeutic application

Also Published As

Publication number Publication date
JP2000178265A (en) 2000-06-27
KR20000047396A (en) 2000-07-25
JP3201998B2 (en) 2001-08-27

Similar Documents

Publication Publication Date Title
KR100914396B1 (en) Process for the preparation of benzoxazine derivatives and intermediates therefor
US5332857A (en) 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents
US4665212A (en) Process for preparing 2-(4-hydroxyphenoxy) alkanoic acid compounds
KR100320772B1 (en) Process for Preparation of (S)-Benzoxazine Derivatives and Process for Racemization of (R)-Benzoxazine Derivatives
KR100511534B1 (en) Amide compound, process for the production
JP2003335756A (en) Method for producing aromatic aldehyde and chiral diol
EP1205476A1 (en) Process for the synthesis of N-(mercaptoacyl)-amino acids derivatives from alpha-substituted acrylic acids
JP2000351776A (en) Production of optically active homocysteinethiolactone salt and its intermediate
FR2540873A1 (en) NOVEL INTERMEDIATES FOR THE PRODUCTION OF 2- (2-AMINOTHIAZOL-4-YL) GLYOXYLIC ACID DERIVATIVES OR ONE OF ITS SALTS AND THE PROCESS FOR THE PRODUCTION OF SAID INTERMEDIATES
KR0142428B1 (en) Process for preparing 1,4-bridged cyclohexane carboxylic acid derivatives and their use
US4577025A (en) Method of preparing α-aromatic propionic acids and intermediates thereof
BE858864A (en) NEW ESTERS OF PHENYL- AND PYRIDINE-3-CARBOXYLIC ACIDS AND PROCESS FOR THEIR PREPARATION
JP4005168B2 (en) Process for producing optically active 2-aryloxypropionic acid
EP1735297B1 (en) Synthesising method and benzoxathiepine intermediates
US4760172A (en) Process for the preparation of optically active 2-(4-methoxyphenoxy) propionic acid
JPH0124782B2 (en)
EP0160241B1 (en) Process for producing an alpha-aromatic group substituted alkanoic acid derivative
JP3569877B2 (en) Method for producing m-substituted-α-hydroxymethylstyrene derivative and 3-chloro-α-bromostyrene
WO2000056716A1 (en) Synthesis of 3-amino-3-aryl propanoates
EP1716088A1 (en) Catalytic asymmetric synthesis of optically active alpha-halo-car bonyl compounds
JP2940395B2 (en) Preparation of oxyglutarate derivatives
JP2923692B2 (en) Enzymatic resolution method
FR2472571A1 (en) PROCESS FOR THE PREPARATION OF HALOGENO-VINCAMINIC AND HALOGENO-APOVINCAMINIC ESTERS DERIVATIVES
EP0179487A1 (en) 2-Phenylpropionic acid esters, method for optical resolution thereof and optically active substance thereof
KR100755151B1 (en) New Process

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090105

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee